Financing

Tax on Share Settlement

Biogen Tax on Share Settlement increased by 126.7% to $55.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 126.7%, from $24.30M to $55.10M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026

How to read this metric

Increases generally correlate with higher levels of stock-based compensation and the timing of equity award vesting cycles.

Detailed definition

Cash payments made by the company to tax authorities on behalf of employees to cover withholding taxes triggered by the...

Peer comparison

Commonly reported by technology companies with significant stock-based compensation programs.

Metric ID: taxes_paid_for_shares

Historical Data

5 periods
 Q1 '22Q1 '23Q1 '24Q1 '25Q1 '26
Value$20.80M$60.10M$46.90M$24.30M$55.10M
QoQ Change+188.9%-22.0%-48.2%+126.7%
YoY Change+188.9%-22.0%-48.2%+126.7%
Range$20.80M$60.10M
CAGR+164.9%
Avg YoY Growth+61.4%
Median YoY Growth+52.4%

Frequently Asked Questions

What is Biogen's tax on share settlement?
Biogen (BIIB) reported tax on share settlement of $55.10M in Q1 2026.
How has Biogen's tax on share settlement changed year-over-year?
Biogen's tax on share settlement increased by 126.7% year-over-year, from $24.30M to $55.10M.
What does tax on share settlement mean?
Cash paid to cover employee taxes on vested stock awards.